110 related articles for article (PubMed ID: 9521436)
21. The effect of tobacco on lung cancer risk depends on CYP2D6 activity.
Bouchardy C; Benhamou S; Dayer P
Cancer Res; 1996 Jan; 56(2):251-3. PubMed ID: 8542575
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.
Hu Z; Xu L; Shao M; Yuan J; Wang Y; Wang F; Yuan W; Qian J; Ma H; Wang Y; Liu H; Chen W; Yang L; Jing G; Huo X; Chen F; Jin L; Wei Q; Wu T; Lu D; Huang W; Shen H
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1336-40. PubMed ID: 16835333
[TBL] [Abstract][Full Text] [Related]
23. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
24. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
25. Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls.
Shaw GL; Weiffenbach B; Falk RT; Frame JN; Issaq HJ; Moir DT; Caporaso N
Lung Cancer; 1997 May; 17(1):61-8. PubMed ID: 9194027
[TBL] [Abstract][Full Text] [Related]
26. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
27. [CYP2D6 and GSTM1 genetic polymorphism and lung cancer susceptibility].
Gao J; Ren C; Zhang Q
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):185-6. PubMed ID: 10921002
[TBL] [Abstract][Full Text] [Related]
28. Rare SP-A alleles and the SP-A1-6A(4) allele associate with risk for lung carcinoma.
Seifart C; Lin HM; Seifart U; Plagens A; DiAngelo S; von Wichert P; Floros J
Clin Genet; 2005 Aug; 68(2):128-36. PubMed ID: 15996209
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in TGF-beta1 gene and the risk of lung cancer.
Kang HG; Chae MH; Park JM; Kim EJ; Park JH; Kam S; Cha SI; Kim CH; Park RW; Park SH; Kim YL; Kim IS; Jung TH; Park JY
Lung Cancer; 2006 Apr; 52(1):1-7. PubMed ID: 16499994
[TBL] [Abstract][Full Text] [Related]
30. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
[TBL] [Abstract][Full Text] [Related]
31. Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer.
Hu Z; Shao M; Chen Y; Zhou J; Qian J; Xu L; Ma H; Wang X; Xu Y; Lu D; Shen H
Cancer Lett; 2006 May; 236(2):269-75. PubMed ID: 16019127
[TBL] [Abstract][Full Text] [Related]
32. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
33. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
34. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility.
Sugimura H; Kohno T; Wakai K; Nagura K; Genka K; Igarashi H; Morris BJ; Baba S; Ohno Y; Gao C; Li Z; Wang J; Takezaki T; Tajima K; Varga T; Sawaguchi T; Lum JK; Martinson JJ; Tsugane S; Iwamasa T; Shinmura K; Yokota J
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):669-74. PubMed ID: 10744126
[TBL] [Abstract][Full Text] [Related]
35. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk.
Roots I; Drakoulis N; Ploch M; Heinemeyer G; Loddenkemper R; Minks T; Nitz M; Otte F; Koch M
Klin Wochenschr; 1988; 66 Suppl 11():87-97. PubMed ID: 2846954
[TBL] [Abstract][Full Text] [Related]
36. Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk.
Jang JS; Kim KM; Choi JE; Cha SI; Kim CH; Lee WK; Kam S; Jung TH; Park JY
Mol Carcinog; 2008 May; 47(5):383-90. PubMed ID: 18058802
[TBL] [Abstract][Full Text] [Related]
37. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
Liu G; Miller DP; Zhou W; Thurston SW; Fan R; Xu LL; Lynch TJ; Wain JC; Su L; Christiani DC
Cancer Res; 2001 Dec; 61(24):8718-22. PubMed ID: 11751390
[TBL] [Abstract][Full Text] [Related]
38. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose.
Nakachi K; Imai K; Hayashi S; Watanabe J; Kawajiri K
Cancer Res; 1991 Oct; 51(19):5177-80. PubMed ID: 1655248
[TBL] [Abstract][Full Text] [Related]
39. Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking.
Agaçhan B; Küçükhüseyin O; Aksoy P; Turna A; Yaylim I; Görmüs U; Ergen A; Zeybek U; Dalan B; Isbir T
Anticancer Res; 2009 Jun; 29(6):2417-20. PubMed ID: 19528510
[TBL] [Abstract][Full Text] [Related]
40. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
